65.Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001 Jun 13;285(22):2864-70. http://www.ncbi.nlm.nih.gov/pubmed/11401607
66.Cisowski M, Bochenek A, Kucewicz E, Wnuk-Wojnar AM, Morawski W, Skalski J, Grzybek H. The use of exogenous creatine phosphate for myocardial protection in patients undergoing coronary artery bypass surgery. J Cardiovasc Surg (Torino). 1996 Dec;37(6 Suppl 1):75-80. http://www.ncbi.nlm.nih.gov/pubmed/10064355
67.Cerný J, N?mec P, Bucek J, Cerný E, Papousek F, Lojek A. The effect of creatine phosphate in patients after surgery in ischemic heart disease. Czech. Vnitr Lek. 1993 Feb;39(2):153-9. http://www.ncbi.nlm.nih.gov/pubmed/8506662